vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Dolby Laboratories, Inc. (DLB). Click either name above to swap in a different company.
Dolby Laboratories, Inc. is the larger business by last-quarter revenue ($395.6M vs $236.8M, roughly 1.7× CROSS COUNTRY HEALTHCARE INC). Dolby Laboratories, Inc. runs the higher net margin — 24.0% vs -35.0%, a 59.0% gap on every dollar of revenue. On growth, Dolby Laboratories, Inc. posted the faster year-over-year revenue change (7.1% vs -23.6%). Over the past eight quarters, Dolby Laboratories, Inc.'s revenue compounded faster (13.9% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Dolby Laboratories, Inc. is an American technology corporation specializing in audio noise reduction, audio encoding/compression, spatial audio, and high-dynamic-range television (HDR) imaging. Dolby licenses its technologies to consumer electronics manufacturers.
CCRN vs DLB — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $395.6M |
| Net Profit | $-82.9M | $94.9M |
| Gross Margin | — | 88.7% |
| Operating Margin | -30.2% | 28.5% |
| Net Margin | -35.0% | 24.0% |
| Revenue YoY | -23.6% | 7.1% |
| Net Profit YoY | -2109.7% | 3.4% |
| EPS (diluted) | $-2.56 | $0.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q2 26 | — | $395.6M | ||
| Q1 26 | — | $346.7M | ||
| Q4 25 | $236.8M | $346.7M | ||
| Q3 25 | $250.1M | $307.0M | ||
| Q2 25 | $274.1M | $315.5M | ||
| Q1 25 | $293.4M | $369.6M | ||
| Q4 24 | $309.9M | $357.0M | ||
| Q3 24 | $315.1M | $304.8M |
| Q2 26 | — | $94.9M | ||
| Q1 26 | — | $53.3M | ||
| Q4 25 | $-82.9M | $53.3M | ||
| Q3 25 | $-4.8M | $49.3M | ||
| Q2 25 | $-6.7M | $46.1M | ||
| Q1 25 | $-490.0K | $91.8M | ||
| Q4 24 | $-3.8M | $67.8M | ||
| Q3 24 | $2.6M | $58.6M |
| Q2 26 | — | 88.7% | ||
| Q1 26 | — | 87.5% | ||
| Q4 25 | — | 87.5% | ||
| Q3 25 | 20.4% | 87.1% | ||
| Q2 25 | 20.4% | 86.1% | ||
| Q1 25 | 20.0% | 90.3% | ||
| Q4 24 | — | 88.6% | ||
| Q3 24 | 20.4% | 88.8% |
| Q2 26 | — | 28.5% | ||
| Q1 26 | — | 17.9% | ||
| Q4 25 | -30.2% | 17.9% | ||
| Q3 25 | -2.4% | 9.7% | ||
| Q2 25 | -2.1% | 15.1% | ||
| Q1 25 | -0.3% | 29.2% | ||
| Q4 24 | -1.1% | 22.4% | ||
| Q3 24 | 0.9% | 15.2% |
| Q2 26 | — | 24.0% | ||
| Q1 26 | — | 15.4% | ||
| Q4 25 | -35.0% | 15.4% | ||
| Q3 25 | -1.9% | 16.1% | ||
| Q2 25 | -2.4% | 14.6% | ||
| Q1 25 | -0.2% | 24.8% | ||
| Q4 24 | -1.2% | 19.0% | ||
| Q3 24 | 0.8% | 19.2% |
| Q2 26 | — | $0.99 | ||
| Q1 26 | — | $0.55 | ||
| Q4 25 | $-2.56 | $0.55 | ||
| Q3 25 | $-0.15 | $0.50 | ||
| Q2 25 | $-0.20 | $0.48 | ||
| Q1 25 | $-0.02 | $0.94 | ||
| Q4 24 | $-0.13 | $0.70 | ||
| Q3 24 | $0.08 | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $594.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $2.6B |
| Total Assets | $449.0M | $3.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | $594.7M | ||
| Q1 26 | — | $644.6M | ||
| Q4 25 | $108.7M | $644.6M | ||
| Q3 25 | $99.1M | $702.6M | ||
| Q2 25 | $81.2M | $699.3M | ||
| Q1 25 | $80.7M | $626.6M | ||
| Q4 24 | $81.6M | $520.8M | ||
| Q3 24 | $64.0M | $482.0M |
| Q2 26 | — | $2.6B | ||
| Q1 26 | — | $2.6B | ||
| Q4 25 | $322.8M | $2.6B | ||
| Q3 25 | $408.1M | $2.6B | ||
| Q2 25 | $412.2M | $2.6B | ||
| Q1 25 | $418.2M | $2.6B | ||
| Q4 24 | $419.0M | $2.5B | ||
| Q3 24 | $424.7M | $2.5B |
| Q2 26 | — | $3.2B | ||
| Q1 26 | — | $3.2B | ||
| Q4 25 | $449.0M | $3.2B | ||
| Q3 25 | $538.2M | $3.2B | ||
| Q2 25 | $553.8M | $3.2B | ||
| Q1 25 | $576.2M | $3.2B | ||
| Q4 24 | $589.3M | $3.2B | ||
| Q3 24 | $597.4M | $3.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $147.3M |
| Free Cash FlowOCF − Capex | $16.1M | — |
| FCF MarginFCF / Revenue | 6.8% | — |
| Capex IntensityCapex / Revenue | 0.9% | — |
| Cash ConversionOCF / Net Profit | — | 1.55× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q2 26 | — | $147.3M | ||
| Q1 26 | — | $54.8M | ||
| Q4 25 | $18.2M | $54.8M | ||
| Q3 25 | $20.1M | $472.2M | ||
| Q2 25 | $4.2M | $67.7M | ||
| Q1 25 | $5.7M | $174.9M | ||
| Q4 24 | $24.2M | $106.8M | ||
| Q3 24 | $7.5M | $327.3M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | $16.1M | $50.2M | ||
| Q3 25 | $17.9M | $435.9M | ||
| Q2 25 | $2.3M | $61.3M | ||
| Q1 25 | $3.8M | $168.0M | ||
| Q4 24 | $21.7M | $100.0M | ||
| Q3 24 | $6.3M | $297.2M |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 14.5% | ||
| Q3 25 | 7.2% | 142.0% | ||
| Q2 25 | 0.8% | 19.4% | ||
| Q1 25 | 1.3% | 45.5% | ||
| Q4 24 | 7.0% | 28.0% | ||
| Q3 24 | 2.0% | 97.5% |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 0.9% | 1.3% | ||
| Q3 25 | 0.9% | 11.8% | ||
| Q2 25 | 0.7% | 2.0% | ||
| Q1 25 | 0.6% | 1.9% | ||
| Q4 24 | 0.8% | 1.9% | ||
| Q3 24 | 0.4% | 9.8% |
| Q2 26 | — | 1.55× | ||
| Q1 26 | — | 1.03× | ||
| Q4 25 | — | 1.03× | ||
| Q3 25 | — | 9.57× | ||
| Q2 25 | — | 1.47× | ||
| Q1 25 | — | 1.91× | ||
| Q4 24 | — | 1.57× | ||
| Q3 24 | 2.92× | 5.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
DLB
| Licensing | $372.2M | 94% |
| Products and services | $23.4M | 6% |
